학술논문
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
Document Type
Article
Author
Lazarus, R.; Wright, J.K.; Kwon, D.; Middleditch, A.; Penciu, F.; Riaz, T.; Finn, A.; Taucher, C.; Čorbic Ramljak, I.; Dubischar, K.; Eder-Lingelbach, S.; Hochreiter, R.; Querton, B.; Brown, C.; Green, C.; Gokani, K.; Naker, K.; Danon, L.; Duncan, C.J.A.; Price, D.; Sanchez-Gonzalez, A.; Wardle, H.; Faust, S.N.; Munro, A.P.S.; Ross-Russell, A.; Warren, S.
Source
In: Journal of Infection . (Journal of Infection, September 2022, 85(3):306-317)
Subject
Language
English
ISSN
15322742
01634453
01634453